Description; Biochem/physiol Actions; Subtype-selective cysteinyl-leukotriene (Cys-Lt) antagonist.; Features and Benefits; This compound is featured on the Leukotriene Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.; This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.